Today, we are exploring a fascinating topic: how real-world data is reshaping the landscape of biosimilars. Dr. Russell Robbins, Chief Medical Information Officer and Dr. Diane Faraone, Senior Director in Pharmacy Analytics, will be discussing how real-world data is not only advancing the development and adoption of biosimilars but also improving access to these vital therapies. So, whether you're a healthcare professional, a patient, or simply curious about the future of medicine, stay tuned for an insightful conversation on the power of data in modern healthcare.